Arjo AB (publ) (STO:ARJO.B)
Sweden · Delayed Price · Currency is SEK 26.14
+0.30 (1.16%)
At close: Jul 10, 2026
Arjo AB Market Cap
Arjo AB has a market cap or net worth of 7.04 billion as of July 10, 2026. Its market cap has decreased by -23.55% in one year.
Market Cap
7.04B
Enterprise Value
11.52B
Revenue
10.84B
Ranking
n/a
PE Ratio
20.05
Stock Price
26.14
Market Cap Chart
Since December 12, 2017, Arjo AB's market cap has increased from 6.71B to 7.04B, an increase of 4.91%. That is a compound annual growth rate of 0.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 7.04B | -19.30% |
| Dec 30, 2025 | 8.72B | -11.69% |
| Dec 30, 2024 | 9.88B | -7.97% |
| Dec 29, 2023 | 10.73B | 1.18% |
| Dec 30, 2022 | 10.61B | -64.86% |
| Dec 30, 2021 | 30.18B | 76.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 162.96B |
| Getinge AB | 55.37B |
| Sectra AB | 54.83B |
| Medicover AB | 34.95B |
| Ambea AB | 11.58B |
| Xvivo Perfusion AB | 8.94B |
| RaySearch Laboratories AB | 7.97B |
| Synsam AB | 7.79B |